Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer.
CONCLUSIONS: Our findings suggest a discrepancy between clinician and PRO reports. Further study may discern potential benefits of collecting PROs in prospective studies and in clinical practice.
PMID: 23077685 [PubMed]
Source: Gastrointestinal Cancer Research - Category: Cancer & Oncology Tags: Gastrointest Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Rectal Cancers | Statistics | Study | Toxicology